Join the team transforming how healthcare is delivered for chronic and specialty conditions worldwide. In General Medicines, you’ll help drive meaningful outcomes in diabetes, transplant, and immunology - with the scale and urgency patients deserve. The Senior Director, US Access Strategy – aT1D & CV&M will lead a small, high-impact team responsible for defining and executing US market access strategies for TZIELD, the first approved disease-modifying therapy for autoimmune type 1 diabetes, as well as for future inline and pipeline assets across the aT1D and cardiovascular & metabolic (CV&M) portfolio. With TZIELD as the near-term priority and cornerstone of the portfolio, this role has end-to-end accountability for short- and long-term access strategy development across national and regional payers, institutional customers, and channel partners, and leads patient support services marketing. The role will leverage deep managed markets and portfolio expertise to build an integrated access strategy aligned with global and US brand objectives, while also preparing the organization for future indication launches. This position will also serve as a key US market access leader for pipeline assets and business development evaluations, bringing a US payer, reimbursement, and pricing perspective to portfolio decision-making. The incumbent must demonstrate strong business acumen, and outstanding communication and interpersonal skills to build productive relationships across internal and external stakeholders. About Sanofi: We’re an R&D-driven, AI-powered biopharma company committed to improving people’s lives and delivering compelling growth. Our deep understanding of the immune system – and innovative pipeline – enables us to invent medicines and vaccines that treat and protect millions of people around the world. Together, we chase the miracles of science to improve people’s lives.
Stand Out From the Crowd
Upload your resume and get instant feedback on how well it matches this job.
Job Type
Full-time
Career Level
Mid Level
Number of Employees
5,001-10,000 employees